RPL26L1
Basic information
Region (hg38): 5:172958729-172969771
Previous symbols: [ "RPL26P1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RPL26L1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 10 | 10 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 10 | 0 | 0 |
Variants in RPL26L1
This is a list of pathogenic ClinVar variants found in the RPL26L1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-172959923-G-A | not specified | Uncertain significance (Nov 10, 2022) | ||
5-172959932-A-G | not specified | Uncertain significance (Jun 01, 2023) | ||
5-172959954-G-T | not specified | Uncertain significance (Jun 07, 2023) | ||
5-172959989-G-A | not specified | Uncertain significance (Aug 26, 2022) | ||
5-172960007-G-A | not specified | Uncertain significance (Oct 25, 2023) | ||
5-172960018-A-T | not specified | Uncertain significance (Jun 10, 2024) | ||
5-172960040-A-C | not specified | Uncertain significance (Mar 29, 2024) | ||
5-172968463-T-A | not specified | Uncertain significance (Dec 14, 2023) | ||
5-172968570-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
5-172968583-G-A | not specified | Uncertain significance (Jun 05, 2023) | ||
5-172969464-C-T | not specified | Uncertain significance (Jan 10, 2022) | ||
5-172969489-G-T | not specified | Uncertain significance (Jun 18, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RPL26L1 | protein_coding | protein_coding | ENST00000521476 | 3 | 11043 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000988 | 0.605 | 125725 | 0 | 22 | 125747 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.229 | 79 | 84.9 | 0.930 | 0.00000477 | 942 |
Missense in Polyphen | 5 | 8.2442 | 0.60649 | 119 | ||
Synonymous | 0.560 | 26 | 29.9 | 0.870 | 0.00000152 | 270 |
Loss of Function | 0.525 | 5 | 6.44 | 0.777 | 4.06e-7 | 72 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000202 | 0.000202 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000123 | 0.000123 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Ribosome - Homo sapiens (human);SRP-dependent cotranslational protein targeting to membrane;Eukaryotic Translation Initiation;Eukaryotic Translation Termination;Translation;Selenocysteine synthesis;Metabolism of proteins;Metabolism of amino acids and derivatives;Metabolism of RNA;Formation of a pool of free 40S subunits;Metabolism;Nonsense-Mediated Decay (NMD);Selenoamino acid metabolism;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);L13a-mediated translational silencing of Ceruloplasmin expression;Peptide chain elongation;Eukaryotic Translation Elongation;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation
(Consensus)
Recessive Scores
- pRec
- 0.124
Intolerance Scores
- loftool
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.25
Haploinsufficiency Scores
- pHI
- 0.136
- hipred
- Y
- hipred_score
- 0.729
- ghis
- 0.676
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.634
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- cytoplasmic translation;ribosomal large subunit biogenesis
- Cellular component
- cytosolic large ribosomal subunit;extracellular exosome
- Molecular function
- RNA binding;structural constituent of ribosome